Results 61 to 70 of about 436,511 (214)
Health Research Funders and Justice: Obligations to Coordinate and Counterbalance
ABSTRACT Government health research funders are frequently criticized on the grounds that their distribution of resources fails to reflect a population's disease burden. These critiques do not take into account what other research funders are doing. In this paper, I argue that this is a mistake.
Joseph Millum
wiley +1 more source
During the 2023–2024 Argentine dengue outbreak, 33 patients with hematological disease showed high complication rates, frequent hospitalization (64%), severe thrombocytopenia (90%), and 6% dengue‐attributable mortality. Transfusion‐associated cases were documented.
Gustavo Adolfo Méndez +16 more
wiley +1 more source
Mucosal‐Associated Invariant T Cells in Health and Disease
The roles of MAIT cells in health and disease and their therapeutic applications. In healthy individuals, riboflavin metabolites secreted by commensal bacteria at mucosal sites are presented by MR1, leading to the activation of MAIT cells. Activated MAIT cells can maintain the barrier integrity of mucosal tissues in a steady state or migrate to the ...
Yu Zhao +5 more
wiley +1 more source
Age and clinical dengue illness. [PDF]
The relationship between age and risk for classic dengue fever has never been quantified. We use data from clinical patients to show that the relative risk of having classical disease after primary dengue virus infection increases with age.
Coleman, Paul G +4 more
core +1 more source
Aedes aegypti females were significantly repelled by both volatile DEET and citronella oil in comparison to control (ethanol‐exposed) mosquitoes. Global gene expression changes were largest in the mosquito mouthparts, with notable downregulation of the three subunits comprising the mosquito CO2 receptor (Gr1, 2 and 3).
Ivan Drahun +3 more
wiley +1 more source
Dengue Vaccine: The Current Status [PDF]
Dengue fever is a re-emerging public health problem with two-fifths of the world population being at risk of infection. Since there are no antiviral drugs available against the dengue virus, and vector control programmes have been largely unsuccessful in preventing outbreaks, vaccination seems to be the most viable option for preventing infection.
M S, Mustafa, V K, Agrawal
openaire +2 more sources
Dengue disease represents a large and growing global threat to public health, causing a significant burden to health systems of endemic countries. For countries considering vaccination as part of their Integrated Management Strategy for Prevention and ...
Giambernardino, H. I.G. +9 more
core +1 more source
Diarrhea and dengue control in rural primary schools in Colombia: study protocol for a randomized controlled trial. [PDF]
BACKGROUND: Diarrheal diseases and dengue fever are major global health problems. Where provision of clean water is inadequate, water storage is crucial.
Vargas Sandra +36 more
core +2 more sources
Dengue epidemic characteristics and vaccine research progress: a review
Dengue fever is a mosquito-borne viral infectious disease transmitted by Aedes mosquitoes carrying the dengue virus (DENV). It is currently prevalent in over 100 tropical and subtropical countries and regions, and was listed by the WHO as one of the "Top
Jun LIU +6 more
doaj +1 more source
Public acceptance and willingness-to-pay for a future dengue vaccine: a community-based survey in Bandung, Indonesia. [PDF]
BackgroundAll four serotypes of dengue virus are endemic in Indonesia, where the population at risk for infection exceeds 200 million people. Despite continuous control efforts that were initiated more than four decades ago, Indonesia still suffers from ...
Panji Fortuna Hadisoemarto +1 more
doaj +1 more source

